GLP-1 and ART — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Yes — no clinically significant interaction between GLP-1 agonists and DTG/BIC/TAF/FTC
Liverpool Drug Interactions confirms no interaction. GLP-1 agonists are a valuable option for PLWH with diabetes/obesity.
Reference: Liverpool Drug Interactions 2024; BHIVA 2025